Studies on the mode of action of alpha-methyldopa.
D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001794:Blood Pressure / Q000187:drug effects*; D001923:Brain Chemistry; D002395:Catecholamines / Q000032:analysis / Q000378:metabolism; D006834:Hydrazines / Q000494:pharmacology; D006973:Hypertension / Q000139:chemically induced; D007267:Injections; D008750:Methyldopa / Q000008:administration & dosage / Q000494:pharmacology*; D008781:Methyltyrosines / Q000494:pharmacology; D009132:Muscles / Q000032:analysis; D009206:Myocardium / Q000032:analysis; D009474:Neurons / Q000187:drug effects* / Q000502:physiology; D011422:Propionates / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000187:drug effects* / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects; D013997:Time Factors
D000614:Aminocaproates; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D002395:Catecholamines; D006834:Hydrazines; D008781:Methyltyrosines; D011422:Propionates; D008750:Methyldopa; D012110:Reserpine